AngioDynamics (ANGO) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free ANGO Stock Alerts $5.81 +0.03 (+0.52%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability AngioDynamics Short Interest DataCurrent Short Volume2,180,000 sharesPrevious Short Volume2,250,000 sharesChange Vs. Previous Month-3.11%Dollar Volume Sold Short$13.76 millionShort Interest Ratio / Days to Cover4.2Last Record DateApril 15, 2024Outstanding Shares40,055,000 sharesPercentage of Shares Shorted5.44%Today's Trading Volume313,347 sharesAverage Trading Volume747,712 sharesToday's Volume Vs. Average42% Short Selling AngioDynamics ? Sign up to receive the latest short interest report for AngioDynamics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatANGO Short Interest Over TimeANGO Days to Cover Over TimeANGO Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> AngioDynamics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,180,000 shares $13.76 million -3.1%N/A4.2 $6.31 3/31/20242,250,000 shares $13.21 million -8.5%N/A3.9 $5.87 3/15/20242,460,000 shares $13.21 million +7.0%N/A4.9 $5.37 2/29/20242,300,000 shares $12.63 million +8.5%N/A4.4 $5.49 2/15/20242,120,000 shares $13.08 million -2.8%N/A4 $6.17 1/31/20242,180,000 shares $12.86 million +26.0%N/A4.2 $5.90 Get the Latest News and Ratings for ANGO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AngioDynamics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,730,000 shares $10.38 million +18.5%N/A3 $6.00 12/31/20231,460,000 shares $11.45 million No ChangeN/A2.5 $7.84 12/15/20231,460,000 shares $10.92 million +3.6%N/A2.6 $7.48 11/30/20231,410,000 shares $9.21 million -2.8%N/A1.9 $6.53 11/15/20231,450,000 shares $10.06 million -2.7%N/A1.9 $6.94 10/31/20231,490,000 shares $9.24 million +60.6%N/A1.9 $6.20 10/15/2023927,900 shares $6.10 million +26.5%N/A1.3 $6.57 9/30/2023733,300 shares $5.36 million -60.4%N/A1 $7.31 9/15/20231,850,000 shares $13.51 million +51.6%4.9%2.8 $7.30 8/31/20231,220,000 shares $9.80 million +24.7%3.2%2.6 $8.03 8/15/2023978,700 shares $8.50 million +45.2%2.6%2.4 $8.69 7/31/2023674,200 shares $5.86 million -10.2%1.8%1.8 $8.69 7/15/2023751,000 shares $7.23 million +3.3%2.0%2.2 $9.63 6/30/2023727,000 shares $7.58 million -13.6%1.9%2.3 $10.43 6/15/2023841,000 shares $9.12 million -5.3%2.2%2.4 $10.85 5/31/2023888,300 shares $8.40 million +16.6%2.3%2.5 $9.46 5/15/2023761,800 shares $7.13 million -7.1%2.0%2.3 $9.36 4/30/2023820,300 shares $6.82 million +8.6%2.2%2.5 $8.32 4/15/2023755,400 shares $6.87 million -18.2%2.0%2.2 $9.09 3/31/2023923,300 shares $9.55 million -16.8%2.4%2.6 $10.34 3/15/20231,110,000 shares $13.58 million -4.3%2.9%3.4 $12.23 2/28/20231,160,000 shares $14.36 million +1.8%3.1%2.8 $12.38 2/15/20231,140,000 shares $14.91 million -14.3%3.0%2.6 $13.08 1/31/20231,330,000 shares $17.32 million -8.3%3.5%2.7 $13.02 1/15/20231,450,000 shares $19.98 million +0.7%3.8%2.7 $13.78 12/30/20221,440,000 shares $19.83 million +52.9%3.8%2.5 $13.77 12/15/2022941,700 shares $11.41 million +3.9%2.5%1.7 $12.12 11/30/2022906,000 shares $11.73 million -5.5%2.4%1.8 $12.95 11/15/2022958,700 shares $13.25 million -13.6%2.5%2.6 $13.82 10/31/20221,110,000 shares $15.64 million -11.2%2.9%3.5 $14.09 10/15/20221,250,000 shares $17.98 million +7.8%3.3%4.8 $14.38 9/30/20221,160,000 shares $23.73 million -10.8%3.1%4.7 $20.46 9/15/20221,300,000 shares $28.65 million +1.6%3.5%7.3 $22.04 8/31/20221,280,000 shares $28.34 million -6.6%3.4%6.2 $22.14Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> ANGO Short Interest - Frequently Asked Questions What is AngioDynamics' current short interest? Short interest is the volume of AngioDynamics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 2,180,000 shares of ANGO short. Learn More on AngioDynamics' current short interest. What is a good short interest ratio for AngioDynamics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANGO shares currently have a short interest ratio of 4.0. Learn More on AngioDynamics's short interest ratio. Which institutional investors are shorting AngioDynamics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AngioDynamics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is AngioDynamics' short interest increasing or decreasing? AngioDynamics saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 2,180,000 shares, a decline of 3.1% from the previous total of 2,250,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does AngioDynamics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to AngioDynamics: Accuray Incorporated (5.49%), Surmodics, Inc. (3.47%), Cytosorbents Co. (2.85%), Orthofix Medical Inc. (10.10%), Utah Medical Products, Inc. (2.64%), TriSalus Life Sciences, Inc. (11.71%), Inovio Pharmaceuticals, Inc. (8.87%), AVITA Medical, Inc. (4.97%), Sight Sciences, Inc. (4.75%), Pulmonx Co. (4.95%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short AngioDynamics stock? Short selling ANGO is an investing strategy that aims to generate trading profit from AngioDynamics as its price is falling. ANGO shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against AngioDynamics? A short squeeze for AngioDynamics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANGO, which in turn drives the price of the stock up even further. How often is AngioDynamics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANGO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Accuray Short Squeeze Surmodics Short Squeeze Cytosorbents Short Squeeze Orthofix Medical Short Squeeze Utah Medical Products Short Squeeze TriSalus Life Sciences Short Squeeze Inovio Pharmaceuticals Short Squeeze AVITA Medical Short Squeeze Sight Sciences Short Squeeze Pulmonx Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ANGO) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace